Literature DB >> 9338098

Cyclin dependent kinase inhibitors.

J W Harper1.   

Abstract

Progression through the eukaryotic cell cycle is regulated by the activities of a family of cyclin dependent kinases (CDKs). These kinases are negatively regulated by phosphorylation and by the action of cyclin kinase inhibitors (CKIs). In mammalian cells, two classes of CKIs have been identified, the INK4 class and the CIP/KIP class. These CKIs are versatile negative regulators of CDK function and have potential roles in development, checkpoint control and tumour suppression. Analysis of CKI knockout indicates that although these inhibitors are not generally required for survival, the phenotypes observed span the gamut of what might be expected for loss of a cell cycle inhibitor. This chapter summarizes our current understanding of the roles of CKIs in growth control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338098

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  21 in total

1.  A quantitative analysis of the kinetics of the G(2) DNA damage checkpoint system.

Authors:  B D Aguda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases.

Authors:  I Blomberg; I Hoffmann
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 4.  Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.

Authors:  Archana Balakrishnan; Arpita Vyas; Kaivalya Deshpande; Dinesh Vyas
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

5.  Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).

Authors:  L Hengst; U Göpfert; H A Lashuel; S I Reed
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

Review 6.  Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects.

Authors:  Kenji Fukasawa
Journal:  Horm Cancer       Date:  2011-04       Impact factor: 3.869

7.  HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.

Authors:  Atish Mukherji; Vaibhao C Janbandhu; Vijay Kumar
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

Review 8.  Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Authors:  Xinjiang Wu; Xianxin Hua
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

9.  Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration.

Authors:  Jiansheng Huang; Emily Barr; David A Rudnick
Journal:  Hepatology       Date:  2013-05       Impact factor: 17.425

10.  The Cyclin-dependent kinase inhibitor Dacapo promotes genomic stability during premeiotic S phase.

Authors:  Karine Narbonne-Reveau; Mary Lilly
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.